mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.01 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
TKI258 |
CCLE |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.01 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.01 |